NASDAQ:BDTX

Black Diamond Therapeutics Earning Date

USA |NASDAQ |USD

BDTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.98 $-0.95 $-0.50
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $0.00 $0.00 $0.00

Black Diamond Therapeutics's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

BDTX Earnings Date & History Chart

BDTX Earnings & Revenue Forecast

BDTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-1.01 $-1.05 $-0.96
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-3.78 $-3.85 $-3.70
Dec 2022 7 $-3.84 $-4.61 $-3.18

BDTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.01 $-0.84 $-0.84
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-3.78 $-3.35 $-3.35
Dec 2022 0 / 0 $-3.84 $-3.73 $-3.73

BDTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $0.00 $0.00 $0.00
Dec 2022 7 $0.00 $0.00 $0.00

BDTX Earnings Date & Revenue History

BDTX Earnings History

|
Show More
Show More

BDTX Revenue History

|
Show More
Show More

Black Diamond Therapeutics Next Earnings Date & Report

BDTX Next Earnings Date & Report Preview: Sep 2021 (FQ)

BDTX's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 6 analysts, the average EPS estimation for Black Diamond Therapeutics's next quarterly earnings is $-0.98, with a low EPS estimation of $-1.01, and a high estimation of $-0.95.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.98, the last 2 month trend is $-0.84, and the 3 month trend is $-0.84.

Based on 5 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Black Diamond Therapeutics Previous Earnings Dates & Reports

BDTX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Black Diamond Therapeutics's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

BDTX's earnings per share (EPS) was $-0.95, missing the consensus analysts forecast of $-0.87 by -9.17%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 13.10%, and lower than the same period a year before (Jun 2020) by 131.71%.

Revenues were $0.00.

The company reported a net income of $-34.35M.

Free cash flow for the quarter was $-26.01M , compared to $-24.50M last quarter and $-13.59M a year before.

BDTX ended the quarter with $13.86M in total debt, a decrease of -2.60% compared to the previous quarter, and an increase of 3364.50% compared to the same quarter a year before.

BDTX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Black Diamond Therapeutics's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

BDTX's earnings per share (EPS) was $-2.05, beating the consensus analysts forecast of $-2.08 by -1.44% , and higher than the previous year's EPS (Dec 2019) by -55.72%.

Revenues were $0.00.

The company reported a net income of $-67.25M.

Black Diamond Therapeutics reported a free cash flow of $-52.29M for its fiscal year, compared to $-24.70M a year ago.

The company ended the fiscal year with $8.74M in total debt. lala